Using RNA test to help diagnose ALS
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study is developing a new RNA test to improve the accuracy of diagnosing amyotrophic lateral sclerosis (ALS). It aims to see if this test can help doctors make a clearer and faster diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been prescribed a genetic test for ALS (or for familial hypercholesterolemia as part of a control group).
- You have given your permission to take part in the genetic study and to donate samples to the biobank.
- You are covered by a health insurance plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with amyotrophic lateral sclerosis (ALS), people who might have ALS, and also people related to someone with ALS. It may help researchers better understand ALS and related “motor neuron” conditions, and it involves participation that may include blood tests.
This study follows healthy people from families with a known ALS-causing gene mutation to look for early body or brain changes before symptoms begin. It may help researchers find ways to predict ALS risk earlier so future treatments can start sooner.
This trial tests a new treatment aimed at restoring the function of a gene called UNC13A in people with ALS. It involves multiple clinic visits, MRI scans, and spinal taps to see if the treatment is safe and may slow the disease.
This study looks at people affected by ALS (a nerve disease) and, in some cases, family members who may be at genetic risk. It may help researchers better understand ALS and related conditions and improve how they’re studied.
This study collects a small skin sample (biopsy) from people with ALS, those who carry an ALS gene mutation but have no symptoms, and healthy volunteers. The sample is used to grow cells in the lab to better understand how ALS develops.
This study looks at genetic (inherited) factors in people with ALS. Your participation may help researchers better understand why ALS happens and who might be at risk.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.